Point prevalence of drug prescriptions for elderly and non-elderly inpatients in a teaching hospital

Sao Paulo Medical Journal

Volumn 122, Issue 2, 2004, Pages 48-52

  Baleeiro Teixeira Braga, Thais ^a   Pfaffenbach, Grace ^a   Weiss, Déborah Peterson Leite ^b   Berti de Azevedo Barros, Marilisa ^a   Bergsten Mendes, Gun ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Aging; Cross sectional study; Elderly; General hospital; Inpatients; Pharmacoepidemiology; Prescription

Indexed keywords

ADIPHENINE; AMINOPHYLLINE; CAPTOPRIL; CEFAZOLIN; CODEINE; DIAZEPAM; DIPYRONE; ENOXAPARIN; FUROSEMIDE; HEPARIN; INSULIN; METOCLOPRAMIDE; METRONIDAZOLE; NIFEDIPINE; PARACETAMOL; PROMETHAZINE; RANITIDINE;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DOSE LIVER FUNCTION RELATION; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG COST; DRUG FATALITY; DRUG POTENTIATION; DRUG SAFETY; DRUG UTILIZATION; ELDERLY CARE; EXTRAPYRAMIDAL SYNDROME; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; PRESCRIPTION; PREVALENCE; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; TEACHING HOSPITAL; TREATMENT PLANNING; UTILIZATION REVIEW;

EID: 2942635193     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802004000200003     Document Type: Article

References (31)

1. Ministério da Saúde. Informações de Saú de. DATASUS. Available from URL: http://tabnet.datasus.gov.br/tabnet/tabnet.htm. Accessed in 2003 (Oct 21).
2. Kalache A, Veras RP, Ramos LR. O envelhecimento da população mundial: um desafio novo. [The ageing of the world's population: a new challenge]. Rev Saúde Pública. 1987;21(3):200-10.
3. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med. 1989;321(5):303-9.
4. Greenblatt DJ, Sellers EM, Shader RI. Drug therapy: drug disposition in old age. N Engl J Med. 1982;306(18):1081-8.
5. Nolan L, O'Malley K. Prescribing for the elderly: Part II. Prescribing patterns: differences due to age. J Am Geriatr Soc. 1988;36(3):245-54.
6. Sotaniemi E, Palva IP. The use of polypharmaceutical drug therapy in a medical ward. Ann Clin Res. 1972;4(3):158-64.
7. Nielsen IK, Osterlind AW, Christiansen LV, et al. Drug consumption and age in a department of internal medicine. Dan Med Bull. 1981;28(2):71-3.
8. Organizacao Mundial da Saude. Manual da classificação estatística internacional de doenças lesões e causas de óbito. São Paulo: Centro da OMS Classif Doencas em Port, 1978.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
10. World Health Organization. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Center for Drug Statistics Methodology; 1996.
11. Christopher LJ, Ballinger BR, Shepherd AM, Ramsay, A, Crooks G. Drug prescribing patterns in the elderly: a cross-sectional study of inpatients. Age Ageing. 1978;7(2):74-82.
12. Rowe JW. Health care of the elderly. N Engl J Med. 1985;312(13):827-35.
13. Miller RR. Drug surveillance utilizing epidemiologic methods. A report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm. 1973;30(7):584-92.
14. Reynolds JEF, editor. Martindale The Extra Pharmacopoeia. 30th ed. London: Pharmaceutical Press; 1993.
15. Remillard AJ. A pharmacoepidemiological evaluation of anticholinergic prescribing patterns in the elderly. Pharmacoepidemiol Drug Saf. 1996;5:155-64.
16. Cusack BJ, Nielson CP, Vestal RE. Geriatric clinical pharmacology and therapeutics. In: Speight TM, Holford NHG, editors. Avery's Drug Treatment. 4th ed. Auckland: Adis Press; 1997.p.173-223.
17. Lisi DM. Drug-induced constipation. Arch Intern Med. 1994;154(4):461, 465, 468.
18. Shorr RI, Griffin MR, Daugherty JR, Ray WA. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol. 1992;47(4):M111-5.
19. World Health Organization. Drugs for the elderly. Copenhagen: WHO; 1989.
20. Porter J, Jick H. Drug-induced anaphylaxis, convulsions, deafness, and extraphyramidal symptoms. Lancet. 1977; 1(8011):587-8.
21. Crooks J. Rational therapeutics in the elderly. J Chron Dis. 1983;36(1):59-65
22. Scharf S, Christophidis N. Relevance of pharmacokinetics and pharmacodynamics. Med J Aust. 1993;158(6):395-402.
23. Bennet WM. Guide to drug dosage in renal failure. In: Speight TM, Holford NHG, editors. Avery's Drug Treatment. 4th ed. Auckland: Adis Press; 1997.p.1725-56.
24. Pahor M, Manto A, Pedone C, Carosella L, Guralnik JM, Carbonin P. Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA). J Clin Epidemiol. 1996;49(8):921-8.
25. Hebert MF. Guide to drug dosage in hepatic disease. In: Speight TM, Holford NHG, editors. Avery's Drug Treatment. 4th ed. Auckland: Adis Press; 1997.p.1761-92.
26. Yusuf S. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation? Circulation. 1995; 92(5):1079-82.
27. Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc. 1995;43(11):1191-7.
28. Ebly EM. Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration. Pharmacoepidemiol Drug Saf. 2000;9:11-23.
29. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316(7):363-9.
30. Tapson VF, Hull RD. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin. Clin Chest Med. 1995;16(2):281-94.
31. Owings JT, Blaisdell FW. Low-dose heparin thromboembolism prophylaxis. Arch Surg. 1996;131(10):1069-73.